Jurgen Thomale
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitization.
Journal: Molecular oncology
Published: July 31, 2025
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer.
Journal: The British journal of surgery
Published: April 26, 2023
Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion.
Journal: Cells
Published: October 04, 2021
RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis.
Journal: Cancers
Published: November 15, 2020
Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
Journal: PloS one
Published: May 22, 2020
Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cells.
Journal: Histochemistry and cell biology
Published: February 19, 2020
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells.
Journal: Molecular oncology
Published: November 27, 2019
Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair.
Journal: Oncogene
Published: September 25, 2018
Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities.
Journal: Scientific reports
Published: August 08, 2018
Last Updated: 09/26/2026